Increased serum interleukin-17 levels in patients with myasthenia gravis
✍ Scribed by Jose C. Roche; Jose L. Capablo; Luis Larrad; Javier Gervas-Arruga; Jose R. Ara; Alejandro SáNCHEZ; Raquel Alarcia
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 149 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Interleukin-10 (IL-10) is a cytokine with immunosuppressive properties. In this study, the authors investigated the prognostic significance of IL-10 levels in the sera of 58 patients with advanced gastric or colorectal carcinoma. ## METHODS. IL-10 serum levels were measured befor
## Abstract Expression of interleukin‐6 (IL‐6) and IL‐6 receptors has been demonstrated in Hodgkin and Reed‐Sternberg (H and RS) cells __in vitro__ and __in vivo__. In order to evaluate the clinical significance of IL‐6 serum levels in patients with Hodgkin's disease (HD), we tested the sera of 56
## Abstract Endostatin is an angiogenesis inhibitor that is an endogenously produced proteolytic fragment of type XVIII collagen. Serum levels of endostatin have been studied extensively in patients with malignant diseases. Recently, elevated serum endostatin levels were observed in patients with s